Filing Details
- Accession Number:
- 0001144204-19-023082
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-01 19:56:25
- Reporting Period:
- 2019-04-04
- Accepted Time:
- 2019-05-01 19:56:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1625288 | Nexien Biopharma Inc. | NXEN | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1579962 | Jeffrey Friedland | 3773 Cherry Creek N. Drive Suite 575 Denver CO 80209 | No | No | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-04-04 | 5,000,000 | $0.09 | 19,000,000 | No | 4 | S | Indirect | By Kanativa USA Inc. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Kanativa USA Inc. |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 833,333 | Direct | |
| Common Stock | 228,800 | Indirect | By Lane 6552 LLC |
Footnotes
- The Reporting Person disclaims all beneficial ownership of the securities owned by Kanativa USA Inc., and this report shall not be deemed an admission of beneficial ownership of such securities by the Reporting Person.
- Kanativa USA Inc. sold 5,000,000 shares effective April 4, 2019.
- In exchange for the sale of the 5,000,000 shares of common stock, Kanativa USA Inc. received 8,500,000 shares of common stock of Phyto Brands Inc., which valued the shares of Nexien BioPharma Inc. at $0.085 per share.
Billionaire Hedge Funds
